Omega Diagnostics Group PLC
LSE:ODX
ROE
Return on Equity
ROE, or Return on Equity, is a key financial ratio that measures a company's profitability. Specifically, it measures how many dollars of profit are generated for each dollar of shareholder's equity. A higher ROE indicates better financial performance and effective use of capital, making it a valuable metric for investors assessing a company's earning potential.
ROE Across Competitors
| Country | Company | Market Cap | ROE | ||
|---|---|---|---|---|---|
| UK |
|
Omega Diagnostics Group PLC
LSE:ODX
|
5.2m GBP |
-35%
|
|
| CH |
|
Alcon AG
SIX:ALC
|
40.2B CHF |
5%
|
|
| JP |
|
Hoya Corp
TSE:7741
|
6.2T JPY |
22%
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
157.1B DKK |
30%
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13.3B USD |
11%
|
|
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
7.4B USD |
33%
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
5.4B GBP |
11%
|
|
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
4.8B CHF |
12%
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
41.2B CNY |
17%
|
|
| US |
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
5.7B USD |
9%
|
|
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
7.5T KRW |
-17%
|
Omega Diagnostics Group PLC
Glance View
Omega Diagnostics Group Plc is a holding company, which engages in the manufacture, development, and distribution of medical diagnostics products. The company is headquartered in Alva, Stirlingshire and currently employs 171 full-time employees. The company went IPO on 2004-03-18. The principal activities of the Company and its subsidiaries are the manufacture, development and distribution of medical diagnostics products. The firm operates through two segments: Health and Nutrition and Global Health. The Health and Nutrition segment specializes in the research, development and production of kits to aid the detection of immune reactions to food. The company also provides clinical analysis to the general public, clinics and health professionals as well as supplying the consumer Food Detective test. The Global Health segment specializes in the research, development, production and marketing of kits to aid the diagnosis of infectious diseases, including COVID-19. The firm's products include FoodPrint, Food Detective, CNS lab, VISITECT CD4 Advanced Disease, VISITECT COVID-19 IgM/IgA/IgG and VISITECT COVID-19 Antigen.
See Also
ROE, or Return on Equity, is a key financial ratio that measures a company's profitability. Specifically, it measures how many dollars of profit are generated for each dollar of shareholder's equity. A higher ROE indicates better financial performance and effective use of capital, making it a valuable metric for investors assessing a company's earning potential.
Based on Omega Diagnostics Group PLC's most recent financial statements, the company has ROE of -35.5%.
You don't have any saved screeners yet